Revelation Biosciences, Inc. (REVB) income statement
REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
$3.50−0.19 (-5.15%)
Close on Nov 20, 2026Market cap $13.94MP/E –Yield –
Revelation Biosciences, Inc. financial ratios
See a number that looks wrong?